Product Information

DOXEPIN 75 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2235 per EA under NDC 64980059701. Its NADAC has been published 130 times since May 29, 2024.

FDA first approved this application on Aug 21, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN 75 MG CAPSULE

Doxepin hydrochloride
$0.2235per EA

Strength

75 mg/1

NDC

64980059701

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA217975

FDA Approved

8/21/2023

TE Code

AB

On Market Since

12/25/2023

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN 75 MG CAPSULE has been published 130 times since May 29, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.2235 per EA
All-time high$0.3160 (Aug 14, 2024)
All-time low$0.1614 (Mar 18, 2026)
52-week high$0.2237
52-week low$0.1614
Median price$0.2113
Average price$0.2150
Largest weekly change-26.8% (Oct 23, 2024)
Weeks tracked130
Tracking sinceMay 29, 2024

Price History

1W

-0.1%

1M

+13.7%

3M

+22.3%

6M

+19.1%

1Y

+19.4%

3Y

N/A

5Y

N/A

All

-0.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXEPIN 75 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN 75 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.2235 per EA (NDC 64980059701), effective Nov 18, 2026.

How has the price of DOXEPIN 75 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DOXEPIN 75 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 130 weekly CMS publications since May 29, 2024.

What are the highest and lowest recorded NADAC prices for DOXEPIN 75 MG CAPSULE?

Since May 29, 2024, the NADAC for DOXEPIN 75 MG CAPSULE has ranged from a low of $0.1614 (Mar 18, 2026) to a high of $0.3160 (Aug 14, 2024), with a median of $0.2113 per EA.

Are there cheaper alternatives to DOXEPIN 75 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXEPIN 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DOXEPIN 75 MG CAPSULE?

DOXEPIN 75 MG CAPSULE (NDC 64980059701) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.